Artelo Biosciences (ARTL) Assets Average (2015 - 2025)
Artelo Biosciences (ARTL) posted quarterly Assets Average of $3.5 million for Q4 2025, down 40.27% year-over-year from $5.9 million in Q4 2024, and down 18.04% quarter-over-quarter from $4.3 million in Q3 2025.
Artelo Biosciences (ARTL) Assets Average (2015 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Assets Average for 11 consecutive years, with $3.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average fell 40.27% year-over-year to $3.5 million; the TTM figure through Dec 2025 stood at $3.5 million (down 40.27% YoY), while the FY2025 annual figure was $3.7 million, down 57.73% from the prior year.
- Assets Average eased to $3.5 million in Q4 2025 per ARTL's latest filing, from $4.3 million in the prior quarter.
- Across five years, Assets Average topped out at $27.9 million in Q1 2022 and bottomed at $3.5 million in Q4 2025.
- Historically, Assets Average has averaged $13.7 million across 5 years, with a median of $12.7 million in 2021.
- Annual changes were most pronounced in 2021 — Assets Average surged 237.25% — and 2025, when it sank 64.9%.
- Artelo Biosciences' Assets Average stood at $20.8 million in 2021, then gained by 2.88% to $21.4 million in 2022, then plunged by 33.37% to $14.3 million in 2023, then slumped by 58.54% to $5.9 million in 2024, then slumped by 40.27% to $3.5 million in 2025.
- Business Quant data shows ARTL's Assets Average at $3.5 million in Q4 2025, $4.3 million in Q3 2025, and $3.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 19.82 Bn |
| 10 | Artelo Biosciences | 113,239.32 | -486,760.68 | - | 3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 3.94 Mn |
| Mar 31, 2025 | 4.11 Mn |
| Dec 31, 2024 | 5.92 Mn |
| Sep 30, 2024 | 7.73 Mn |
| Jun 30, 2024 | 9.34 Mn |
| Mar 31, 2024 | 11.70 Mn |
| Dec 31, 2023 | 14.27 Mn |
| Sep 30, 2023 | 16.19 Mn |
| Jun 30, 2023 | 17.68 Mn |
| Mar 31, 2023 | 19.45 Mn |
| Dec 31, 2022 | 21.42 Mn |
| Sep 30, 2022 | 23.41 Mn |
| Jun 30, 2022 | 25.55 Mn |
| Mar 31, 2022 | 27.85 Mn |
| Nov 30, 2021 | 20.82 Mn |
| Aug 31, 2021 | 12.49 Mn |
| May 31, 2021 | 12.89 Mn |
| Feb 28, 2021 | 11.49 Mn |